Reduced dysbindin expression mediates N-methyl-D-aspartate receptor hypofunction and impaired working memory performance

Biological Psychiatry

Volumn 69, Issue 1, 2011, Pages 28-34

  Karlsgodt, Katherine H ^a,b   Robleto, Karla ^a   Trantham Davidson, Heather ^c   Jairl, Corey ^a   Cannon, Tyrone D ^a,b   Lavin, Antonieta ^c   Jentsch, J David ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

DTNBP1; Dysbindin; Glutamate; NMDA; Schizophrenia; Working memory

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYLISOXAZOLE 4 PROPIONIC ACID RECEPTOR; DYSBINDIN; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSOCIATION; COGNITION; COGNITIVE DEFECT; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; GENE EXPRESSION; IN VITRO STUDY; MALE; MENTAL PERFORMANCE; MOUSE; MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SPATIAL MEMORY; WHOLE CELL; WORKING MEMORY;

ANIMALS; CARRIER PROTEINS; DOWN-REGULATION; FEMALE; MALE; MEMORY, SHORT-TERM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PATCH-CLAMP TECHNIQUES; PREFRONTAL CORTEX; PYRAMIDAL CELLS; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 78650006680     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2010.09.012     Document Type: Article

References (46)

1. T.D. Cannon, J. Kaprio, J. Lonnqvist, M. Huttunen, and M. Koskenvuo The genetic epidemiology of schizophrenia in a Finnish twin cohort A population-based modeling study Arch Gen Psychiatry 55 1998 67 74
2. A.G. Cardno, and I.I. Gottesman Twin studies of schizophrenia: From bow-and-arrow concordances to star wars Mx and functional genomics Am J Med Genet 97 2000 12 17
3. R.E. Straub, C.J. MacLean, F.A. O'Neill, J. Burke, B. Murphy, and F. Duke A potential vulnerability locus for schizophrenia on chromosome 6p24-22: Evidence for genetic heterogeneity Nat Genet 11 1995 287 293
4. S.G. Schwab, M. Knapp, S. Mondabon, J. Hallmayer, M. Borrmann-Hassenbach, and M. Albus Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families Am J Hum Genet 72 2003 185 190
5. R.E. Straub, C.J. MacLean, Y. Ma, B.T. Webb, M.V. Myakishev, and C. Harris-Kerr Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes Mol Psychiatry 7 2002 542 559
6. J.X. Tang, J. Zhou, J.B. Fan, X.W. Li, Y.Y. Shi, and N.F. Gu Family-based association study of DTNBP1 in 6p22.3 and schizophrenia Mol Psychiatry 8 2003 717 718
7. G. Kirov, D. Ivanov, N.M. Williams, A. Preece, I. Nikolov, and R. Milev Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria Biol Psychiatry 55 2004 971 975
8. J. Tang, R.P. LeGros, N. Louneva, L. Yeh, J.W. Cohen, and C.G. Hahn Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression Hum Mol Genet 18 2009 3851 3863
9. C.S. Weickert, R.E. Straub, B.W. McClintock, M. Matsumoto, R. Hashimoto, and T.M. Hyde Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain Arch Gen Psychiatry 61 2004 544 555
10. C.S. Weickert, D.A. Rothmond, T.M. Hyde, J.E. Kleinman, and R.E. Straub Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients Schizophr Res 98 2008 105 110
11. K. Talbot, W.L. Eidem, C.L. Tinsley, M.A. Benson, E.W. Thompson, and R.J. Smith Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia J Clin Invest 113 2004 1353 1363
12. K.E. Burdick, T. Lencz, B. Funke, C.T. Finn, P.R. Szeszko, and J.M. Kane Genetic variation in DTNBP1 influences general cognitive ability Hum Mol Genet 15 2006 1563 1568
13. J.R. Zinkstok, O. de Wilde, T.A. van Amelsvoort, M.W. Tanck, F. Baas, and D.H. Linszen Association between the DTNBP1 gene and intelligence: A case-control study in young patients with schizophrenia and related disorders and unaffected siblings Behav Brain Funct 3 2007 19
14. D. Posthuma, M. Luciano, E.J. Geus, M.J. Wright, P.E. Slagboom, and G.W. Montgomery A genomewide scan for intelligence identifies quantitative trait loci on 2q and 6p Am J Hum Genet 77 2005 318 326
15. J.F. Hallmayer, L. Kalaydjieva, J. Badcock, M. Dragovic, S. Howell, and P.T. Michie Genetic evidence for a distinct subtype of schizophrenia characterized by pervasive cognitive deficit Am J Hum Genet 77 2005 468 476
16. Wolf C, Jackson MC, Kissling C, Thome J, Linden D (in press): Dysbindin-1 genotype effects on emotional working memory. Mol Psychiatry.
17. G. Donohoe, D.W. Morris, S. Clarke, K.A. McGhee, S. Schwaiger, and J.M. Nangle Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: A preliminary study Neuropsychologia 45 2007 454 458 (Pubitemid 44828767)
18. D.C. Glahn, S. Therman, M. Manninen, M. Huttunen, J. Kaprio, J. Lonnqvist, and T.D. Cannon Spatial working memory as an endophenotype for schizophrenia Biol Psychiatry 53 2003 624 626
19. T.D. Cannon, M.O. Huttunen, J. Lonnqvist, A. Tuulio-Henriksson, T. Pirkola, and D. Glahn The inheritance of neuropsychological dysfunction in twins discordant for schizophrenia Am J Hum Genet 67 2000 369 382
20. P.S. Goldman-Rakic Working memory dysfunction in schizophrenia J Neuropsychiatr Clin Neurosci 6 1994 348 357
21. A.J. Fallgatter, M.J. Herrmann, C. Hohoff, A.C. Ehlis, T.A. Jarczok, C.M. Freitag, and J. Deckert DTNBP1 (dysbindin) gene variants modulate prefrontal brain function in healthy individuals Neuropsychopharmacology 31 2006 2002 2010
22. J.D. Jentsch, H. Trantham-Davidson, C. Jairl, M. Tinsley, T.D. Cannon, and A. Lavin Dysbindin modulates prefrontal cortical glutamatergic circuits and working memory function in mice Neuropsychopharmacology 34 2009 2601 2608
23. T. Numakawa, Y. Yagasaki, T. Ishimoto, T. Okada, T. Suzuki, and N. Iwata Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia Hum Mol Genet 13 2004 2699 2708
24. X.W. Chen, Y.Q. Feng, C.J. Hao, X.L. Guo, X. He, and Z.Y. Zhou DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release J Cell Biol 181 2008 791 801
25. E.D. Luby, B.D. Cohen, G. Rosenbaum, J.S. Gottlieb, and R. Kelley Study of a new schizophrenomimetic drug; sernyl AMA Arch Neurol Psychiatry 81 1959 363 369
26. J.H. Krystal, L.P. Karper, J.P. Seibyl, G.K. Freeman, R. Delaney, and J.D. Bremner Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans Psychotomimetic, perceptual, cognitive, and neuroendocrine responses Arch Gen Psychiatry 51 1994 199 214
27. J.D. Jentsch, and R.H. Roth The neuropsychopharmacology of phencyclidine: From NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia Neuropsychopharmacology 20 1999 201 225
28. W. Li, Q. Zhang, N. Oiso, E.K. Novak, R. Gautam, and E.P. O'Brien HermanskyPudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1) Nat Genet 35 2003 84 89
29. W. Marrs, J. Kuperman, T. Avedian, R.H. Roth, and J.D. Jentsch Alpha-2 adrenoceptor activation inhibits phencyclidine-induced deficits of spatial working memory in rats Neuropsychopharmacology 30 2005 1500 1510
30. S.M. Aarde, and J.D. Jentsch Haploinsufficiency of the arginine-vasopressin gene is associated with poor spatial working memory performance in rats Horm Behav 49 2006 501 508
31. P.S. Goldman-Rakic Cellular basis of working memory Neuron 14 1995 477 485
32. K. Talbot, D.S. Cho, W.Y. Ong, M.A. Benson, L.Y. Han, and H.A. Kazi Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin Hum Mol Genet 15 2006 3041 3054
33. R.C. Carroll, and R.S. Zukin NMDA-receptor trafficking and targeting: Implications for synaptic transmission and plasticity Trends Neurosci 25 2002 571 577
34. K. Newell-Litwa, E. Seong, M. Burmeister, and V. Faundez Neuronal and non-neuronal functions of the AP-3 sorting machinery J Cell Sci 120 2007 531 541
35. S. Taneichi-Kuroda, S. Taya, T. Hikita, Y. Fujino, and K. Kaibuchi Direct interaction of dysbindin with the AP-3 complex via its mu subunit Neurochem Int 54 2009 431 438
36. L.M. Camargo, V. Collura, J.C. Rain, K. Mizuguchi, H. Hermjakob, and S. Kerrien Disrupted in Schizophrenia 1 Interactome: Evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia Mol Psychiatry 12 2007 74 86
37. K.E. Burdick, T.E. Goldberg, B. Funke, J.A. Bates, T. Lencz, R. Kucherlapati, and A.K. Malhotra DTNBP1 genotype influences cognitive decline in schizophrenia Schizophr Res 89 2007 169 172
38. H. Silver, P. Feldman, W. Bilker, and R.C. Gur Working memory deficit as a core neuropsychological dysfunction in schizophrenia Am J Psychiatry 160 2003 1809 1816
39. M.F. Green What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153 1996 321 330
40. K.H. Karlsgodt, D.C. Glahn, T.G. van Erp, S. Therman, M. Huttunen, and M. Manninen The relationship between performance and fMRI signal during working memory in patients with schizophrenia, unaffected co-twins, and control subjects Schizophr Res 89 2007 191 197
41. J.D. Jentsch, D.E. Redmond Jr, J.D. Elsworth, J.R. Taylor, K.D. Youngren, and R.H. Roth Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine Science 277 1997 953 955
42. J.D. Jentsch, J.D. Elsworth, J.R. Taylor, D.E. Redmond Jr, and R.H. Roth Dysregulation of mesoprefrontal dopamine neurons induced by acute and repeated phencyclidine administration in the nonhuman primate: implications for schizophrenia Adv Pharmacol 42 1998 810 814
43. B.P. Sokolov Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of "neuroleptic-free" schizophrenics: Evidence on reversible up-regulation by typical neuroleptics J Neurochem 71 1998 2454 2464
44. M. Beneyto, and J.H. Meador-Woodruff Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder Neuropsychopharmacology 33 2008 2175 2186
45. S. Akbarian, N.J. Sucher, D. Bradley, A. Tafazzoli, D. Trinh, and W.P. Hetrick Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics J Neurosci 16 1996 19 30
46. S. Dracheva, S.A. Marras, S.L. Elhakem, F.R. Kramer, K.L. Davis, and V. Haroutunian N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia Am J Psychiatry 158 2001 1400 1410